Several studies have demonstrated the correlation between overexpression of lysophosphatidylcholine acyltransferase 1 (LPCAT1), a crucial enzyme influencing PC metabolism and remodeling, with the progression of various malignancies, including CRC [65–67]. The gene discussed is LPCAT1; the disease is colorectal carcinoma.